A Robust IPO Market--even for Devices?
Executive Summary
Anyone who stood in the packed room at this year's Chase Hambrecht & Quist meeting in San Francisco in early January for the presentation by e-commerce player Neoforma.com Inc. could hardly be surprised by the results of the company's IPO, which went out the week following, raising $91 million for the B2B supply chain manager. But as well as the Neoforma public offering did, it was, arguably, nothing compared to the IPO of Aspect Medical Systems Inc., a manufacturer of depth-of-anesthesia monitoring devices.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.